T
Teligent Inc (NEW JERSEY)
OTC:TLGTQ
Teligent Inc (NEW JERSEY)
OTC:TLGTQ
Price:
0.0002 USD
Updated:
May 7, 2024
Teligent Inc (NEW JERSEY)
Operating Income
|
Teligent Inc (NEW JERSEY)
Operating Income Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
T
|
Teligent Inc (NEW JERSEY)
OTC:TLGTQ
|
Operating Income
-$38.4m
|
CAGR 3-Years
-48%
|
CAGR 5-Years
-64%
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Operating Income
$24.3B
|
CAGR 3-Years
4%
|
CAGR 5-Years
4%
|
CAGR 10-Years
3%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Operating Income
$10.5B
|
CAGR 3-Years
14%
|
CAGR 5-Years
6%
|
CAGR 10-Years
12%
|
|
|
Pfizer Inc
NYSE:PFE
|
Operating Income
$10.6B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
11%
|
CAGR 10-Years
-5%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Operating Income
$6.1B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-3%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Operating Income
$11.3B
|
CAGR 3-Years
19%
|
CAGR 5-Years
15%
|
CAGR 10-Years
9%
|
See Also
What is Teligent Inc (NEW JERSEY)'s Operating Income?
Operating Income
-38.4m
USD
-38.4m
USD
Based on the financial report for Dec 31, 2020, Teligent Inc (NEW JERSEY)'s Operating Income amounts to -38.4m USD.
What is Teligent Inc (NEW JERSEY)'s Operating Income growth rate?
Operating Income CAGR 5Y
-64%
-64%
Over the last year, the Operating Income growth was -379%. The average annual Operating Income growth rates for Teligent Inc (NEW JERSEY) have been -48% over the past three years , -64% over the past five years .
You don't have any saved screeners yet
